| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Clearside Biomedical, Inc. (CLSDQ) has 0 insiders with recent SEC Form 4 filings, including 3 buys and 21 sells. CLSDQ is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 19, 2017 | Thorp Clay62 | Director, 10% Owner | Sell | 68,485 | $7.46 | $510,944.50 | -0.6% | |
| Apr 4, 2017 | White Daniel H. | President And CEO | Sell | 8,000 | $7.55 | $60,400.00 | -0.7% | |
| Mar 27, 2017 | Cagle Gerald D. | Director | Buy | 14,064 | $7.10 | $99,854.40 | New | |
| Mar 20, 2017 | Shaffer Christy L | Director | Buy | 2,200 | $6.90 | $15,180.00 | New | |
| Mar 16, 2017 | Cagle Gerald D. | Director | Buy | 5,000 | $6.84 | $34,200.00 | +84.2% | |
| Mar 16, 2017 | Thorp Clay62 | Director, 10% Owner | Sell | 68,485 | $6.56 | $449,543.45 | -0.8% | |
| Feb 22, 2017 | Thorp Clay62 | Director, 10% Owner | Sell | 27,000 | $7.55 | $203,730.00 | -0.3% | |
| Feb 17, 2017 | Thorp Clay62 | Director, 10% Owner | Sell | 41,485 | $7.60 | $315,105.40 | -0.3% | |
| Jan 20, 2017 | Thorp Clay62 | Director, 10% Owner | Sell | 68,485 | $8.53 | $584,001.55 | -0.4% | |
| Jan 19, 2017 | Hatteras Venture Advisors Iii, LLC | 10% Owner, May Be Part Of A 13(d) Group | Sell | 25,301 | $8.63 | $218,222.36 | -0.5% |